Medical Marijuana Market Analysis By Application, (Chronic Pain, Arthritis, Migraine, Cancer) By Country And Segment Forecasts, 2013 - 2025

  • ID: 4076534
  • Report
  • 70 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Cannabis Sativa, Inc.
  • CannaGrow Holdings, Inc.
  • Cara Therapeutics Inc.
  • Growblox Sciences, Inc.
  • GW Pharmaceuticals plc
  • Lexaria Corp.
  • MORE
The global medical marijuana market is expected to reach a value of USD 55.8 billion by 2025. It has been identified that, in 2016, Washington D.C. along with 28 states have legalized marijuana for medical uses. In 2016, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania were approved to use the drug in medical applications such as chemotherapies and pain management. The growing number of states and countries getting approval for using it in therapeutic applications is one of the crucial factors driving the demand over the coming few years.

The presence of several regulatory frameworks such as the Medical Marijuana Regulation and Safety Act is indicators of the present demand for the drug in the market. The regulatory framework requires every individual or the company associated such as growers, retail operators, and makers of processed pot products to obtain permission and an annual state license from 2018. An increasing number of issued licenses is also among factors that is expected to drive the market especially after 2018.

The increasing interest amongst the academic researchers and healthcare providers regarding the therapeutic uses of marijuana is among the significant factors, which is driving the market over the coming years. Some of its potential therapeutic values are suppression of vomiting & nausea, pain relief, and appetite stimulation. In addition, research states that marijuana is effective in providing relief to the patient suffering from HIV/AIDS, glaucoma, cancer, and multiple sclerosis. The growing number of therapeutic applications of the drug is one of the key factors that is propelling the market over the forecast period.

Further key findings from the study suggest:

In 2015, chronic pain was the largest application segment owing to the presence of a huge patient base

The growing prevalence of chronic pain elevates the demand for the drug, thus expected to boost the medical marijuana for chronic pain management

The rapidly growing number of cannabis legalization in the U.S. is one of the key attributes for its increased demand in therapeutic and recreational uses, and thus anticipated to impel the market growth

Increasing investment in R&D & demand for cannabis in chemotherapy is expected to drive the growth in the Asia Pacific market

Some of the key players are Cara Therapeutics Inc.; CannaGrow Holdings, Inc.; Cannabis Sativa, Inc.; United Cannabis Corporation; GrowBlox Sciences, Inc.; GW Pharmaceuticals, plc; Lexaria Corp; International Consolidated Companies, Inc.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cannabis Sativa, Inc.
  • CannaGrow Holdings, Inc.
  • Cara Therapeutics Inc.
  • Growblox Sciences, Inc.
  • GW Pharmaceuticals plc
  • Lexaria Corp.
  • MORE
1 Research Methodology

2 Executive Summary
2.1 Market Snapshot

3 Medical Marijuana Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.2 Market restraint analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Medical Marijuana- SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.4 Industry Analysis - Porter’s

4 Medical Marijuana Application Estimates & Trend Analysis
4.1 Medical Marijuana Market: Application Movement Analysis
4.2 Chronic Pain
4.2.1 Chronic pain market estimates and forecasts, 2013 - 2025 (USD Million)
4.3 Arthritis
4.3.1 Arthritis market estimates and forecasts, 2013 - 2025 (USD Million)
4.4 Migraine
4.4.1 Migraine market estimates and forecasts, 2013 - 2025 (USD Million)
4.5 Cancer
4.5.1 Cancer market estimates and forecasts, 2013 - 2025 (USD Million)
4.6 Other
4.6.1 Other market estimates and forecasts, 2013 - 2025 (USD Million)

5 Medical Marijuana Regional Estimates & Trend Analysis, by Application
5.1 Medical Marijuana Market Share by Region, 2013 & 2025
5.2 North America
5.2.1 North America medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.2 Belgium
5.3.2.1 Belgium medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.3 Croatia
5.3.3.1 Croatia medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.4 Finland
5.3.4.1 Finland medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.5 France
5.3.5.1 France medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.6 Italy
5.3.6.1 Italy medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.7 Netherlands
5.3.7.1 Netherlands medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.8 Portugal
5.3.8.1 Portugal medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.9 Romania
5.3.9.1 Romania medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.10 Switzerland
5.3.10.1 Switzerland medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.11 Czech Republic
5.3.11.1 Czech Republic medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.12 Estonia
5.3.12.1 Estonia medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.4 ROW
5.4.1 ROW medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.4.2 Israel
5.4.2.1 Israel medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)

6 Competitive Landscape
6.1 Cara Therapeutics Inc.
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives
6.2 Cannabis Sativa, Inc.
6.2.1 Company overview
6.2.2 Financial performance
6.2.3 Product benchmarking
6.2.4 Strategic initiatives
6.3 CannaGrow Holdings, Inc.
6.3.1 Company overview
6.3.2 Financial performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 United Cannabis Corporation
6.4.1 Company overview
6.4.2 Financial performance
6.4.3 Product benchmarking
6.4.4 Strategic initiatives
6.5 United Cannabis Corporation
6.5.1 Company overview
6.5.2 Financial performance
6.5.3 Product benchmarking
6.5.4 Strategic initiatives
6.6 Growblox Sciences, Inc.
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
6.6.4 Strategic initiatives
6.7 GreenGro Technologies, Inc.
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives
6.8 GW Pharmaceuticals plc
6.8.1 Company overview
6.8.2 Financial performance
6.8.3 Product benchmarking
6.8.4 Strategic initiatives
6.9 International Consolidated Companies, Inc.
6.9.1 Company overview
6.9.2 Financial performance
6.9.3 Product benchmarking
6.9.4 Strategic initiatives
6.10 Lexaria Corp.
6.10.1 Company overview
6.10.2 Financial performance
6.10.3 Product benchmarking
6.10.4 Strategic initiatives

List of Tables

Table 1 North America medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 2 U.S. medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 3 Canada medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 4 Europe medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 5 Belgium medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 6 Croatia medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 7 Finland medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 8 France medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 9 Italy medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 10 Netherlands medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 11 Portugal medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 12 Romania medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 13 Switzerland medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 14 Czech Republic medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 15 Estonia medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 16 ROW medical marijuana market, by application, 2013 - 2025 (USD Million)
Table 17 Israel medical marijuana market, by application, 2013 - 2025 (USD Million)

List of Figures

Figure 1 Market summary
Figure 2 Market trends & outlook
Figure 3 Market segmentation & scope
Figure 4 Market driver relevance analysis (Current & future impact)
Figure 5 Market restraint relevance analysis (Current & future impact)
Figure 6 Penetration & growth prospect mapping
Figure 7 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 8 Porter’s five forces analysis
Figure 9 Medical marijuana market: Application outlook key takeaways
Figure 10 Medical marijuana market: Application movement analysis
Figure 11 Global chronic pain market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 12 Global arthritis market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 13 Global migraine market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 14 Global cancer market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 15 Global other market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 16 Regional market place: Key takeaways
Figure 17 Regional outlook, 2015 & 2025
Figure 18 North America medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 19 U.S. medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 20 Canada medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 21 Europe medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 22 Belgium medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 23 Croatia medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 24 Finland medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 25 France medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 26 Italy medical marijuana market estimates, by product, 2013 - 2015 (USD Million)
Figure 27 Netherlands medical marijuana market estimates, by product, 2013 - 2015 (USD Million)
Figure 28 Portugal medical marijuana market estimates, by product, 2013 - 2015 (USD Million)
Figure 29 Romania medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 30 Switzerland medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 31 Czech Republic medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 32 Estonia medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 33 ROW medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Figure 34 Israel medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Cara Therapeutics Inc.
  • Cannabis Sativa, Inc.
  • CannaGrow Holdings, Inc.
  • United Cannabis Corporation
  • United Cannabis Corporation
  • Growblox Sciences, Inc.
  • GreenGro Technologies, Inc.
  • GW Pharmaceuticals plc
  • International Consolidated Companies, Inc.
  • Lexaria Corp.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll